Sidoti & Co. analyst James Sidoti upgrades Staar Surgical (NASDAQ:STAA) from Neutral to Buy.
Sidoti & Co. Upgrades Staar Surgical to Buy
Sidoti & Co. analyst James Sidoti upgrades Staar Surgical (NASDAQ:STAA) from Neutral to Buy.
Related Posts
Milestone Pharmaceuticals Announced Saturday: Results from ReVeRA Phase 2 Study of Etripamil in AFib-RVR Showed Statistically Significant Reduction In Ventricular Rate By 30 Beats Per Minute For Episodes Of Atrial Fibrillation With Rapid Ventricular Ra…
Milestone Pharmaceuticals Inc. (NASDAQ:MIST) today announced positive Phase 2 data that show etripamil nasal spray resulted in rapid and statistically superior ventricular rate reduction and improved symptom-relief in
Organon FY23 Reiterates Revenue Outlook $6.15B – $6.45B Vs. $6.28B Estimate
Full year 2023 financial guidance is presented below on a non-GAAP basis.
Previous guidance as of
February 16, 2023
Current
Expert Outlook: Veritex Holdings Through The Eyes Of 4 Analysts
Across the recent three months, 4 analysts have shared their insights on Veritex Holdings (NASDAQ:VBTX), expressing a variety…